Concepedia

Peter N. Weissman

PN

Statistics

Publications

12

Citations

1.1K

H-Index

11

Active since

1971

Affiliations

GlaxoSmithKline (United States)(Current)

University of Michigan

Indiana University – Purdue University Indianapolis

Universidad Europea de Madrid

University of Chicago

Peter N. Weissman is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

1971–2023

12

Publications

12

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

, , +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

, , +17

Chlorpropamide Hyponatremia

Peter N. Weissman, Robert I. Gregerman · New England Journal of Medicine · 1971 · 151 citations

, , +10

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea

Peter N. Weissman, Molly C. Carr, June Ye et al. · Diabetologia · 2014 · 134 citations · Full text

, , +12

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

, , +17

1–5 of 12